-transparent.png){kind=logo}
We have constructed an in vitro system to examine how p53 mutants affect radiosensitivity. Mutations of p53 were made using in vitro mutagenesis, and mutant cDNAs were introduced into the human osteosarcoma cell line, Saos-2, which is devoid of endogenous p53. For wild type p53, both the expression plasmid and a regulation plasmid (LacSwitch system) were transfected into the cells. The radiosensitivities of clones of mutant p53 and wild type p53 were examined. Transformants of wild type p53 had increased radiosensitivity. The induction of wild type p53 protein by addition of IPTG did not significantly increased radiosensitivity. A mutation at codon 123 also increased radiosensitivity. Mutations at codons 143, 175, and 273 did not alter radiosensitivity.
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
January 2008,
Anticancer research,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
October 2001,
American journal of clinical oncology,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
June 2011,
Anticancer research,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
November 1996,
Toxicology and applied pharmacology,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
June 2013,
Clinical cancer research : an official journal of the American Association for Cancer Research,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
February 2003,
Cancer chemotherapy and pharmacology,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
June 2021,
Cell death discovery,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
September 1996,
Cytometry,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
January 2005,
Journal of bone and mineral metabolism,
K Okaichi, and
L H Wang, and
M Ihara, and
Y Okumura
July 2016,
Oncotarget,
